<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The objective of this study was to assess the effect of therapeutic moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on excitatory amino acids and metabolism by applying cerebral microdialysis in patients suffering from space-occupying <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This was an open, prospective, observational study of 12 patients undergoing moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (33 degrees C) as rescue therapy for large, life-threatening <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Microdialysis probes were placed concomitantly with intracranial pressure (ICP) measuring devices in the frontal lobe of the infarcted and/or noninfarcted hemisphere </plain></SENT>
<SENT sid="3" pm="."><plain>Using the CMA 600 Microdialysis Autoanalyzer, we analyzed <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="3" ids="17754">glycerol</z:chebi>, <z:chebi fb="1" ids="15361">pyruvate</z:chebi>, and <z:chebi fb="4" ids="24996">lactate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: According to follow-up cranial CT scans, 3 different compartments of microdialysis measurements could be defined </plain></SENT>
<SENT sid="5" pm="."><plain>First, noninfarcted brain tissue had stable dialysate concentrations but a significant effect of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (2.6 versus 3.6 micromol/L), <z:chebi fb="4" ids="24996">lactate</z:chebi> (1.8 versus 3 mmol/L), and <z:chebi fb="1" ids="15361">pyruvate</z:chebi> (50 versus 95.8 micromol/L) </plain></SENT>
<SENT sid="6" pm="."><plain>Second, measurements from peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> tissue had a significant effect of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (4.8 versus 12.6 micromol/L), <z:chebi fb="3" ids="17754">glycerol</z:chebi> (58 versus 82 micromol/L), <z:chebi fb="4" ids="24996">lactate</z:chebi> (0.7 versus 1.3 mmol/L), and <z:chebi fb="1" ids="15361">pyruvate</z:chebi> (13.3 versus 36.8 micromol/L) </plain></SENT>
<SENT sid="7" pm="."><plain>Third, dialysate concentrations obtained from irreversibly damaged tissue were excessive for <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (453 micromol/L), <z:chebi fb="3" ids="17754">glycerol</z:chebi> (1187 micromol/L), <z:chebi fb="4" ids="24996">lactate</z:chebi> (12 micromol/L), and <z:chebi fb="1" ids="15361">pyruvate</z:chebi> (4 micromol/L) </plain></SENT>
<SENT sid="8" pm="."><plain>In this extreme compartment, no effect of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was observed </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Cerebral microdialysis is a safe and feasible bedside method for neurochemical monitoring indicating <z:mpath ids='MPATH_458'>normal</z:mpath> brain tissue, potentially salvageable brain tissue, and irreversibly damaged areas in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>We could demonstrate that <z:hpo ids='HP_0002045'>hypothermia</z:hpo> decreases <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="3" ids="17754">glycerol</z:chebi>, <z:chebi fb="4" ids="24996">lactate</z:chebi>, and <z:chebi fb="1" ids="15361">pyruvate</z:chebi> in the "tissue at risk" area of the <z:mpath ids='MPATH_124'>infarct</z:mpath> but not within the <z:mpath ids='MPATH_124'>infarct</z:mpath> core </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, future treatment strategies for life-threatening <z:hpo ids='HP_0001297'>stroke</z:hpo> should be guided by close neurochemical monitoring </plain></SENT>
</text></document>